Thursday, February 21, 2019 2:20:01 PM
$BSGM is developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology marketplace. They recently announced that the Company successfully conducted the first patient cases using PURE EP™ System, its FDA approved proprietary signal acquisition and processing technology. The first commercial use of the System was completed at the Texas Cardiac Arrhythmia Institute in Austin, TX. https://finance.yahoo.com/news/future-now-med-tech-changing-130000888.html
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
